Amdoxovir is a nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV/AIDS. It was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia). It is being developed by RFS Pharma. Currently, it is in Phase II clinical studies.
Can we infer the following?
Amdoxovir could eventually be available on the market as an HIV/AIDS treatment

Options are:
a). Yes.
b). It's impossible to say.
c). No.
The answer is:
a).